Research graph
References from Fatal drug-induced liver injury in the setting of abemaciclib therapy for metastatic breast cancer. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1200/jco.2017.73.7585
10.1200/jco.2017.73.7585 · External reference
10.1056/nejmoa1607303
10.1056/nejmoa1607303 · External reference
10.1200/jco.2017.75.6155
10.1200/jco.2017.75.6155 · External reference
10.1002/onco.13531
10.1002/onco.13531 · External reference
10.21873/anticanres.16114
10.21873/anticanres.16114 · External reference
10.1136/flgastro-2021-101886
10.1136/flgastro-2021-101886 · External reference
Unresolved reference
External reference
Abemaciclib, Palbociclib, and Ribociclib in Real-World Data: A Direct Comparison of First-Line Treatment for Endocrine-Receptor-Positive Metastatic Breast Cancer
10.3390/ijms24108488 · 2023 · External reference
The Roles of Cyclin-Dependent Kinases in Cell-Cycle Progression and Therapeutic Strategies in Human Breast Cancer
10.3390/ijms21061960 · 2020 · External reference
10.1016/s1470-2045(14)71159-3
10.1016/s1470-2045(14)71159-3 · External reference
10.1056/nejmoa1911149
10.1056/nejmoa1911149 · External reference
10.1056/nejmoa1609709
10.1056/nejmoa1609709 · External reference
CDK4/6 inhibitors: basics, pros, and major cons in breast cancer treatment with specific regard to cardiotoxicity - a narrative review
10.1177/17588359231205848 · 2023 · External reference
Side effects of CDK4/6 inhibitors in the treatment of HR+/HER2- advanced breast cancer: a systematic review and meta-analysis of randomized controlled trials
10.21037/apm-21-1096 · 2021 · External reference
Adverse Cardiovascular Events Associated With Cyclin-Dependent Kinase 4/6 Inhibitors in Patients With Metastatic Breast Cancer
10.1161/jaha.123.029361 · 2023 · External reference
10.1080/14737140.2019.1674651
10.1080/14737140.2019.1674651 · External reference
Strategies for Early Prediction and Timely Recognition of Drug-Induced Liver Injury: The Case of Cyclin-Dependent Kinase 4/6 Inhibitors
10.3389/fphar.2019.01235 · 2019 · External reference
CDK4/6 inhibitors in drug-induced liver injury: a pharmacovigilance study of the FAERS database and analysis of the drug-gene interaction network
10.3389/fphar.2024.1378090 · 2024 · External reference
Acute-on-Chronic Liver Failure Incited by Cyclin-Dependent Kinase Inhibitor Therapy for Breast Cancer Effectively Treated With Liver Transplantation
10.14309/crj.0000000000001253 · 2024 · External reference
Fatal acute hepatic failure secondary to thrombotic portal venopathy after commencing abemaciclib and fulvestrant treatment for advanced breast carcinoma: a unique autopsy finding
10.1111/tbj.14238 · 2021 · External reference
Unresolved reference
External reference
Aromatase inhibitors induced autoimmune disorders in patients with breast cancer: A review
10.1016/j.jare.2016.04.001 · 2016 · External reference
10.21873/anticanres.15992
10.21873/anticanres.15992 · External reference
An exploratory study on prediction of risk for abemaciclib-induced interstitial lung disease or hepatotoxicity by specific human leukocyte antigen alleles
10.1200/jco.2024.42.16_suppl.3087 · 2024 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
10.1111/tbj.13532
10.1111/tbj.13532 · External reference
10.1016/j.breast.2020.10.007
10.1016/j.breast.2020.10.007 · External reference
Palbociclib-induced severe hepatitis: A case study and literature review
10.3138/canlivj-2021-0015 · 2021 · External reference
CDK4/6 inhibitor-induced liver injury: Clinical phenotypes and role of corticosteroid treatment
10.1016/j.jhepr.2024.101098 · 2024 · External reference
Prednisolone therapy accelerates recovery of severe drug-induced liver injury: A prospective, randomized controlled study
10.1016/j.iliver.2023.06.001 · 2023 · External reference
Role of Corticosteroids in Drug-Induced Liver Injury. A Systematic Review
10.3389/fphar.2022.820724 · 2022 · External reference
Potential benefit and lack of serious risk from corticosteroids in drug-induced liver injury: An international, multicentre, propensity score-matched analysis
10.1111/apt.17373 · 2023 · External reference
Steroid and Ursodesoxycholic Acid Combination Therapy in Severe Drug-Induced Liver Injury
10.1159/000322298 · 2011 · External reference
Role of Ursodeoxycholic Acid in Treating and Preventing Idiosyncratic Drug-Induced Liver Injury. A Systematic Review
10.3389/fphar.2021.744488 · 2021 · External reference
